The Next Generation Oral Selective Estrogen Receptor Degrader (SERD) Camizestrant (AZD9833) is Active Against Wild Type and Mutant Estrogen Receptor Α
Christopher Morrow,Larissa Carnevalli,Richard D. Baird,Tim Brier,Carmela Ciardullo,Natalie Cureton,Mandy Lawson,Robert McEwen,Myria Nikolaou,Anne Armstrong,Begona Bermejo,Emiliano Calvo,Eva Ciruelos,Javier Garcia-Corbacho,Erika Hamilton,Jason Incorvati,Peter Kabos,Mafalda Oliveira,Manish R. Patel,Manuel Ruiz-Borrego,Nicholas Turner,Chris Twelves,Christos Vaklavas,Danielle Carroll, Steven Ching,Nevena Cvetesic,Michelle DuPont,Lisa Gibbons,Alastair Mathewson,Rhiannon Maudsley,Pablo Morentin Gutierrez,Avinash Reddy,Jaime Rodriguez-Canales,Susana Ros,Dhivya Sudhan,Andy Sykes, David Whitson,Teresa Klinowska,Justin Lindemann CANCER RESEARCH(2023)
AI 理解论文
溯源树
样例